Rethinking eligibility creep - 24/04/13
Funding sources: None. |
|
Disclosure: Dr Leonardi has been a member of the advisory board, a speaker, and an investigator for Amgen, Genentech, Centocor, and Abbott; a member of the advisory board and speaker for Warner-Chillcott; and an investigator for Bristol Myers. Dr Gordon has been a member of the advisory board, an investigator, and consultant for Abbott, Amgen, Centocor, and Genentech. Dr Strober has been a member of the advisory board, a speaker, and consultant for Abbott, Amgen, Centocor, Genentech, and Astellas. Dr Kimball has been an investigator, speaker, and consultant for Abbott, Centocor, and Amgen. Dr Menter has been a consultant, speaker, investigator, and member of the advisory board for Abbott, Amgen, Astellas, Centocor, Genentech, Warner Chilcott, and Wyeth. Ms Kazanis has no relevant conflicts of interest to declare. |
|
Reprint requests: harvardskinstudies@partners.org |
Vol 59 - N° 1
P. 165-167 - juillet 2008 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?